Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESIcare for Urinary Incontinence in Parkinson's Disease
NCT00584090Phase 4Withdrawn
- Sponsor
- University of South Florida
- Start
- Nov 2007
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of solifenacin in urinary incontinence (UI), sponsored by University of South Florida. Primary endpoint: Efficacy of solifenacin succinate on treating urinary incontinence at 1 month. Planned start Nov 2007; status: withdrawn.
02
Drugs
solifenacin
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NCT00584090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584090.